These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8336400)

  • 21. [Serum and urinary pyridinium cross-links in patients with predialysis chronic renal failure].
    Kagebayashi Y; Samma S; Yoshida K; Ozono S; Motomiya Y; Hirao Y; Fujii Y; Kishimoto T; Dohi K; Okajima E
    Nihon Jinzo Gakkai Shi; 1996 Jun; 38(6):248-53. PubMed ID: 8752966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evaluation of renal osteodystrophy with cortical quantitative ultrasound at various bone sites.
    da Costa JA; de Castro JA; Foss MC
    Ren Fail; 2004 May; 26(3):237-41. PubMed ID: 15354971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of biochemical with radiological findings in renal osteodystrophy.
    Moorhead JF; Varghese Z; Tatler GL; Baillod RA; Wills MR
    Ann Clin Biochem; 1975 May; 12(3):126-31. PubMed ID: 15637920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal osteodystrophy with hyperparathyroidism: the diagnostic value of intact parathormone, alkaline phosphatase, osteocalcin and procollagen.
    Rubini G; Anelli F; Correale M; Lauriero F; Rubini D; D'Addabbo A
    J Nucl Biol Med (1991); 1994 Sep; 38(3):489-94. PubMed ID: 7865545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of renal osteodystrophy in hemodialysis patients.
    DeVita MV; Rasenas LL; Bansal M; Gleim GW; Zabetakis PM; Gardenswartz MH; Michelis MF
    Medicine (Baltimore); 1992 Sep; 71(5):284-90. PubMed ID: 1522804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Renal osteodystrophy in patients on maintenance hemodialysis: statistical study of clinical, radiological and biochemical features].
    Zwahlen A; Leski M; Burckhardt P; Assimacopoulos A; Garcia J; Szary L; Courvoisier B
    Schweiz Med Wochenschr; 1981 Jan; 111(5):154-6. PubMed ID: 7280647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Renal osteodystrophy and growth in children undergoing CAPD].
    Ito T; Horiike S; Iitaka K
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):779-90. PubMed ID: 1770638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Free 4-hydroxyproline content in serum of bedridden aged people is elevated due to fracture.
    Koike K; Li Y; Seo M; Sakurada I; Tezuka K; Uchikura K
    Biol Pharm Bull; 2000 Jan; 23(1):101-3. PubMed ID: 10706420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations between bone histopathology and serum biochemistry in uremic patients on chronic hemodialysis.
    Canavese C; Barolo S; Gurioli L; Cadario A; Portigliatti M; Isaia G; Thea A; Marangella M; Bongiorno P; Cavagnino A; Peona C; Boero R; D'Amicone M; Cardelli R; Rossi P; Piccoli G
    Int J Artif Organs; 1998 Aug; 21(8):443-50. PubMed ID: 9803345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
    López Gavilanes E; González Parra E; de la Piedra C; Caramelo C; Rapado A
    Miner Electrolyte Metab; 1994; 20(5):259-64. PubMed ID: 7700213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
    Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
    Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
    [No Abstract]   [Full Text] [Related]  

  • 32. The hydroxyproline content of plasma of patients with impaired renal function.
    Hart W; Duursma SA; Visser WJ; Njio LK
    Clin Nephrol; 1975; 4(3):104-8. PubMed ID: 1183097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skeletal surveys in renal osteodystrophy.
    Mohini R; Dumler F; Rao DS
    ASAIO Trans; 1991; 37(4):635-7. PubMed ID: 1768501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of renal osteodystrophy: when and how to use biochemical markers and non-invasive methods; when bone biopsy is needed.
    Ferreira MA
    Nephrol Dial Transplant; 2000; 15 Suppl 5():8-14. PubMed ID: 11073268
    [No Abstract]   [Full Text] [Related]  

  • 35. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlations between osteodensitometry and parameters of uremic osteodystrophy].
    Sforzini S; Viganò MR; Beretta P; Rosa M; d'Amico P; Lomuscio G; Paesani R
    Minerva Med; 1985 Mar; 76(9-10):445-8. PubMed ID: 3982703
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
    Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
    Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
    [No Abstract]   [Full Text] [Related]  

  • 38. Renal osteodystrophy in hemodialysis patients.
    Oda H; Yorioka N; Takemasa A; Shigemoto K; Harada S; Ito T; Masaki T; Yamakido M
    Hiroshima J Med Sci; 1995 Sep; 44(3):83-8. PubMed ID: 8567317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal osteodystrophy: a complex disorder.
    Kumar R
    J Lab Clin Med; 1979 Jun; 93(6):895-8. PubMed ID: 438609
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of risk factors for radiographic hyperparathyroidism in 422 patients with end-stage renal disease: development of a clinical predictive index.
    Pazianas M; Phillips ME; MacRae KD; Eastwood JB
    Nephrol Dial Transplant; 1992; 7(11):1098-105. PubMed ID: 1336136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.